VEDO 2005: A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease Long-term Safety With Vedolizumab IV in Pediatric Subjects With Ulcerat

Project: Research project

Project Details

StatusActive
Effective start/end date6/1/18 → 8/31/50

Funding

  • Takeda Pharmaceuticals